News
This is but a fact that obesity drugs are only going to get more accessible for Indians post March 2026. But whether they make us healthier depends on how we use them. If they become another ...
Serena Williams used GLP-1s to lose weight after having children, the tennis star says in a new ad campaign for online ...
Novo Nordisk raced to meet demand for its weight-loss drug Wegovy and almost doubled its workforce over five years. Now, the ...
After a 20% stock plunge, Denmark's prized drugmaker triggers fears over jobs, confidence, and consumer spending.
SERENA Williams has revealed she used fat jabs to shed pounds after giving birth to her two daughters. The tennis star has ...
Pedersen and Maggie Fick COPENHAGEN (Reuters) -As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the ...
Influencer Tana Mongeau questioned if she had Ozempic vulva on TikTok, after reported side effect goes viral online.
As Novo Nordisk's sales of its blockbuster weight-loss drug Wegovy boomed, the Danish drugmaker raced to expand manufacturing ...
No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish ...
Hyderabad-based Natco Pharma has filed a lawsuit against Danish drugmaker Novo Nordisk, the maker of blockbuster weight-loss ...
With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030.
Ascendis Pharma's TransCon platform shows promise, but challenges with rollout, competition, and execution risks lead to a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results